Dexmedetomidine as an anesthetic adjuvant in patients undergoing transsphenoidal resection of pituitary tumor

Journal of Neurosurgical Anesthesiology

Volumn 27, Issue 3, 2015, Pages 209-215

  Gopalakrishna, Kadarapura N ^a   Dash, Prasanta K ^b   Chatterjee, Nilay ^b   Easwer, Hariharan V ^c   Ganesamoorthi, Arimanickam ^d  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^c Kerala Institute of Medical Sciences ^*  (India)

^d Meenakshi Hospital   (India)

Author keywords

anesthetic adjuvant; dexmedetomidine; entropy; hemodynamic; pituitary surgery; recovery

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; ISOFLURANE; OXYGEN; PLACEBO; PROPOFOL; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; VECURONIUM; CENTRAL DEPRESSANT AGENT; HYPNOTIC SEDATIVE AGENT; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT;

ADJUVANT THERAPY; ADULT; ANESTHESIA INDUCTION; ARTICLE; BRAIN SURGERY; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTIVE SURGERY; ENDOTRACHEAL INTUBATION; ENTROPY; EXTUBATION; FEMALE; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; HYPOPHYSIS TUMOR; MALE; MEAN ARTERIAL PRESSURE; NEUROMUSCULAR MONITORING; PERIOPERATIVE PERIOD; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRANSNASAL TRANSSPHENOIDAL RESECTION; TRANSSPHENOIDAL SURGERY; TREATMENT RESPONSE; ANALYSIS OF VARIANCE; ANESTHETIC RECOVERY; DRUG EFFECTS; HEMODYNAMICS; MIDDLE AGED; NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY; PITUITARY NEOPLASMS; PROCEDURES; SPHENOID SINUS;

ADJUVANTS, ANESTHESIA; ADULT; ANALYSIS OF VARIANCE; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; DEXMEDETOMIDINE; DOUBLE-BLIND METHOD; FENTANYL; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; ISOFLURANE; MIDDLE AGED; NATURAL ORIFICE ENDOSCOPIC SURGERY; PITUITARY NEOPLASMS; PROSPECTIVE STUDIES; SODIUM CHLORIDE; SPHENOID SINUS;

EID: 84932192324     PISSN: 08984921     EISSN: 15371921     Source Type: Journal    
DOI: 10.1097/ANA.0000000000000144     Document Type: Article

References (39)

1. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999; 54: 146-165
2. Maze M, Scarfini C, Cavaliere F. New agents for sedation in the intensive care unit. Crit Care Clin. 2001; 17: 881-897
3. Bekker A, Sturaitis MK. Dexmedetomidine for neurological surgery. Neurosurgery. 2005; 57: 1-10
4. Kamibayashi T, Maze M. Clinical uses of alpha2-Adrenergic agonists. Anesthesiology. 2000; 93: 1345-1349
5. Ali Z, Prabhakar H, Bithal PK, et al. Bispectral index-guided administration of anesthesia for transsphenoidal resection of pituitary tumors: a comparison of 3 anesthetic techniques. J Neurosurg Anesthesiol. 2009; 21: 10-15
6. Gadhinglajkar SV, Sreedhar R, Bhattacharya RN. Carotid artery injury during transsphenoidal resection of pituitary tumor. J Neurosurg Anesthesiol. 2003; 15: 323-326
7. Sawka AM, Aniszewski JP, Young WF Jr, et al. Tension pneumocranium, a rare complication of transsphenoidal pituitary surgery: Mayo Clinic experience 1976-1998. J Clin Endocrinol Metab. 1999; 84: 4731-4734
8. Boogaerts JG, Vanacker E, Seidel L, et al. Assessment of postoperative nausea using a visual analogue scale. Acta Anaesthesiol Scand. 2000; 44: 470-474
9. Keniya VM, Ladi S, Naphade R. Dexmedetomidine attenuates sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirement. Indian J Anaesth. 2011; 55: 352-357
10. Bekker A, Sturaitis M, Bloom M, et al. The effect of dexmedetomidine on perioperative hemodynamics in patients undergoing craniotomy. Anesth Analg. 2008; 107: 1340-1347
11. Ozkose Z, Demir FS, Pampal K, et al. Hemodynamic and anesthetic advantages of dexmedetomidine, an alpha 2-Agonist, for surgery in prone position. Tohoku J Exp Med. 2006; 210: 153-160
12. Gurbet A, Basagan-Mogol E, Turker G, et al. Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth. 2006; 53: 646-652
13. Arain SR, Ruehlow RM, Uhrich TD, et al. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg. 2004; 98: 153-158
14. Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care. Rev Bras Anestesiol. 2012; 62: 118-133
15. Sturaitis M, Kroin J, Swamidoss C, et al. Effects of intraoperative dexmedetomidine infusion on hemodynamic stability during brain tumor resection. Anesthesiology. 2002; 98: A-310
16. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-Analysis. Intensive Care Med. 2010; 36: 926-939
17. Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000; 90: 699-705
18. Scheinin B, Lindgren L, Randell T, et al. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. Br J Anaesth. 1992; 68: 126-131
19. Aantaa R, Jaakola ML, Kallio A, et al. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology. 1997; 86: 1055-1060
20. Khan ZP, Munday IT, Jones RM, et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers 1: pharmacodynamic and pharmacokinetic interactions. Br J Anaesth. 1999; 83: 372-380
21. Bloor BC, Ward DS, Belleville JP, et al. Effects of intravenous dexmedetomidine in humans II hemodynamic changes. Anesthesiology. 1992; 77: 1134-1142
22. McCallum JB, Boban N, Hogan Q, et al. The mechanism of alpha2-Adrenergic inhibition of sympathetic ganglionic transmission. Anesth Analg. 1998; 87: 503-510
23. Talke P, Chen R, Thomas B, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000; 90: 834-839
24. Yasemin G, Mediha T, Tahsin E, et al. Anesthesia for craniotomy: comparison of sevoflurane, desflurane, or isoflurane anesthesia supplemented with an infusion of dexmedetomidine during supratentorial craniotomy. Neurosurg Q. 2009; 19: 110-115
25. Yildiz M, Tavlan A, Tuncer S, et al. Effect of dexmedetomidine on haemodynamic responses to laryngoscopy and intubation : perioperative haemodynamics and anaesthetic requirements. Drugs R D. 2006; 7: 43-52
26. Tanskanen PE, KyttäJV, Randell TT, et al. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, randomized and placebo-controlled study. Br J Anaesth. 2006; 97: 658-665
27. Balakrishnan G, Raudzens P, Samra SK, et al A comparison of remifentanil and fentanyl in patients undergoing surgery for intracranial mass lesions. Anesth Analg. 2000; 91: 163-169
28. Guy J, Hindman BJ, Baker KZ, et al. Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions. Anesthesiology. 1997; 86: 514-524
29. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999; 54: 1136-1142
30. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000; 93: 382-394
31. Muzzi DA, Black S, Losasso TJ, et al. Labetalol and esmolol in the control of hypertension after intracranial surgery. Anesth Analg. 1990; 70: 68-71
32. Kross RA, Ferri E, Leung D, et al A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-betablocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. Anesth Analg. 2000; 91: 904-909
33. Magalhaes E, Goveia CS, Ladeira LC, et al. Relationship between dexmedetomidine continuous infusion and end-Tidal sevoflurane concentration, monitored by bispectral analysis. Rev Bras Anestesiol. 2004; 54: 303-310
34. Ellerkmann RK, Liermann VM, Alves TM, et al. Spectral entropy and bispectral index as measures of the electroencephalographic effects of sevoflurane. Anesthesiology. 2004; 101: 1275-1282
35. White PF, Tang J, Romero GF, et al A comparison of state and response entropy versus bispectral index values during the perioperative period. Anesth Analg. 2006; 102: 160-167
36. Maksimow A, Snapir A, SärkeläM, et al. Assessing the depth of dexmedetomidine-induced sedation with electroencephalogram (EEG)-based spectral entropy. Acta Anaesthesiol Scand. 2007; 51: 22-30
37. Kaskinoro K, Maksimow A, LångsjöJ, et al. Wide inter-individual variability of bispectral index and spectral entropy at loss of consciousness during increasing concentrations of dexmedetomidine, propofol, and sevoflurane. Br J Anaesth. 2011; 107: 573-580
38. Gupta N, Rath GP, Prabhakar H, et al. Effect of intraoperative dexmedetomidine on postoperative recovery profile of children undergoing surgery for spinal dysraphism. J Neurosurg Anesthesiol. 2013; 25: 271-278
39. Okawa H, Ono T, Hashiba E, et al. Decreased postoperative nausea and vomiting with dexmedetomidine after off-pump coronary artery bypass grafting. Crit Care. 2011; 15(suppl 1): 351